Create
Learn
Share

Onco midterm

rename
boyepark's version from 2017-05-03 20:48

Section

Mechlorethamine
Bendamustine
Cyclophosphamide
Ifosfamide
Melphalan
Chlorambucil
Busulfan
Thiotepa
Altretamine
Dacarbazine
Procarbazine
Temozolomide
Carmustine
Lomustine
Cisplatin
Carboplatin
Oxaliplatin
Mitomycin
Azacitidine
Decitabine
Methotrexate
Premetrexed
Pralatrexate
Cladribine
Clofarabine
Fludarabine
Mercaptopurine/6-MP
Thioguanine
Nelarabine
Pentostatin
Cytarabine
Flurouracil
Capecitabine
Gemcitibine
Trifluridine/Tipiracil
Floxuridine
Ixabepilone
Cabazitaxel
Docetaxel
Paclitaxel
Paclitaxel protein bound
Vinblastine
Vincristine
Vincristine liposomal
Vinorelbine
Eribulin
Panobinostat
Belinostat
Romidepsin
Vorinostat
Irinotecan
Irinotecan liposomal
Topotecan
Doxorubicin
Doxorubicin liposomal
Daunorubicin
Daunorubicin liposomal
Epirubicin
Idarubicin
Valrubicin
Mitoxantrone
Etoposide
Etoposide phosphate
Teniposide
Arsenic trioxide
Asparaginase
Pegasparaginase
Bleomycin
Tretinoin/ATRA
Bexarotene
Dactinomycin
Hydroxyurea
Mitoxane
Omacetaxine
Trabectedin
Cetuximab
Necitumumab
Panitumumab
Osimertinib
Trastuzumab
Pertuzumab
Ado-Trastuzumab emtansine
Bevacizumab
Ramucirumab
Blinatumomab
Brentuximab
Rituximab
Daratumumab
Elotuzumab
Ibritumomab
Obinutuzumab
Ofatumumab
Ipilimumab
Nivolumab
Pembrolizumab
Atezolizumab
Dinutuximab
Gefitinib
Erlotinib
Lapatinib
Afatinib
Axitinib
Pazopanib
Sorafenib
Sunitinib
Ziv-Afllibercept
Lenvatinib
Regorafenib
Alectinib
Ceritinib
Crizotinib
Dasatinib
Nilotinib
Imatinib
Ponatinib
Bosutinib
Olaparib
Rucaparib
Palbociclib
Sonidegib
Vismodegib
Ibrutinib
Idelalisib
Ruxolitinib
Trametinib
Cobimetinib
Dabrafenib
Vemurafenib
Bortezomib
Carfilzomib
Ixazomib
Everolimus
Temsirolimus
Thalidomide
Lenalidomide
Pomalidomide
Aldesleukin
Interferon alfa-2b
Sipuleucel-T
Talimogene Laherparepvec
Vandetanib
Alemtuzumab
Olaratumab
Venetoclax